A tyrosine kinase inhibitor lenvatinib is oxidized by human cytochromes P450 and aldehyde oxidase in vitro

FEBS OPEN BIO

Vavrova, K; Indra, R; Pompach, P; Heger, Z; Adam, V; Eckschlager, T; Kopeckova, K; Stiborova, M, 2018: A tyrosine kinase inhibitor lenvatinib is oxidized by human cytochromes P450 and aldehyde oxidase in vitro. FEBS OPEN BIO 8, p. 351 - 351

Research Groups:

CEITEC authors: